Used in pharmaceutical research as a key intermediate for developing nicotinic acetylcholine receptor (nAChR) modulators. It is particularly valuable in the synthesis of compounds targeting neurological disorders such as Alzheimer's disease, schizophrenia, and nicotine addiction. Its structure allows for selective binding and improved pharmacokinetic properties in drug candidates. Also employed in the development of PET tracers for imaging brain receptors in clinical and preclinical studies.